Records containing: Peanut Allergy
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2022-06-30Open-label Follow-up Study of the VIPES Study to Evaluate Long-term Efficacy and Safety of the Viaskin Peanut
-
CLINICAL_TRIALS study record update · 2022-05-19A Study to Evaluate the Efficacy and Safety of Dupilumab Monotherapy in Pediatric Patients With Peanut Allergy
-
CLINICAL_TRIALS study record update · 2022-03-17Peanut Allergy Oral Immunotherapy Study of AR101 for Desensitization in Children and Adults (PALISADE)
-
CLINICAL_TRIALS study record update · 2022-02-02Peanut Allergy Oral Immunotherapy Desensitization
-
CLINICAL_TRIALS study record update · 2021-12-16Peanut Sublingual Immunotherapy Induction of Clinical Tolerance of Newly Diagnosed Peanut Allergic 12 to 48 Month Old Children
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2021-12-15Peanut Allergy Oral Immunotherapy Study of AR101 for Desensitization in Children and Adults (PALISADE) Follow-on Study
-
CLINICAL_TRIALS study record update · 2021-11-17Subthreshold Peanut in Infants - Understanding Plasticity
-
CLINICAL_TRIALS study record update · 2021-11-09Oral Desensitization to Peanut in Peanut-Allergic Children and Adults Using Characterized Peanut Allergen (CPNA) Peanut Oral Immunotherapy (OIT) Safety Follow-On Study
-
CLINICAL_TRIALS study record update · 2021-11-02Phase 2 Oral Desensitization to Peanut in Peanut-Allergic Children and Adults Using Characterized Peanut Allergen Oral Immunotherapy
-
CLINICAL_TRIALS study record update · 2021-11-02Real-World AR101 Market-Supporting Experience Study in Peanut-Allergic Children Ages 4 to 17 Years (RAMSES)
-
CLINICAL_TRIALS study record update · 2021-11-02Real-World AR101 Market-Supporting Experience Study in Peanut-Allergic Children, Active Treatment Arm Open-Label Extension Study (RAMSES OLE)
-
CLINICAL_TRIALS study record update · 2021-10-27A Double-blind, Placebo-controlled, Randomized Trial to Study the Viaskin Peanut's Efficacy and Safety for Treating Peanut Allergy in Children and Adults.
-
CLINICAL_TRIALS study record update · 2021-10-15A Double-blind, Placebo-controlled, Randomized Phase 3 Pivotal Trial to Assess the Efficacy and Safety of Peanut Epicutaneous Immunotherapy With Viaskin Peanut in Peanut-allergic Children
-
CLINICAL_TRIALS study record update · 2021-09-05A Phase I Open Label Trial to Evaluate the Safety and Efficacy of Oral Encapsulated Fecal Microbiota Transplantation in Peanut Allergic Patients
-
CLINICAL_TRIALS study record update · 2021-08-03AR101 Trial in Europe Measuring Oral Immunotherapy Success in Peanut Allergic Children (ARTEMIS)
-
CLINICAL_TRIALS study record update · 2021-07-28Clinical Desensitization and Tolerance Following Peanut Oral Immunotherapy and Subsequent Allergen Avoidance
-
CLINICAL_TRIALS study record update · 2021-07-13Peanut Allergy Oral Immunotherapy Study of AR101 for Desensitization in Children and Adolescents: Real World, Open Label, Quality of Life Study
-
CLINICAL_TRIALS study record update · 2021-05-28Viaskin® Peanut (DBV712) Expanded Access Protocol in Peanut-Allergic Children
-
CLINICAL_TRIALS study record update · 2021-05-14Allergology: Information, Data and Knowledge Organization
-
CLINICAL_TRIALS study record update · 2021-05-11Oral Low Doses Tolerance INduction Study for Peanuts
-
CLINICAL_TRIALS study record update · 2021-02-03ClinicalTrials.gov study NCT02916446
-
CLINICAL_TRIALS study record update · 2020-12-02Open-label Follow-up Study of the PEPITES Study to Evaluate the Long-term Efficacy and Safety of Viaskin Peanut
-
CLINICAL_TRIALS study record update · 2020-11-27Clinical Validation of the Inactivation Procedure for Peanut Major Allergens in the HYPONUT Product
-
CLINICAL_TRIALS study record update · 2020-10-19The Utility of Food-Specific IgE Measured With the IMMULITE 2000 Assay to Predict Symptomatic Food Allergy
-
CLINICAL_TRIALS study record update · 2020-06-04Disease Management: Canadian Peanut Thresholds Study